Advances in the treatment of chronic myeloid leukemia

Although imatinib is firmly established as an effective therapy for newly diagnosed patients with chronic myeloid leukemia (CML), the field continues to advance on several fronts. In this minireview we cover recent results of second generation tyrosine kinase inhibitors in newly diagnosed patients,...

Descripción completa

Detalles Bibliográficos
Autores principales: Eiring, Anna M, Khorashad, Jamshid S, Morley, Kimberly, Deininger, Michael W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182901/
https://www.ncbi.nlm.nih.gov/pubmed/21867560
http://dx.doi.org/10.1186/1741-7015-9-99

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182901/
https://www.ncbi.nlm.nih.gov/pubmed/21867560
http://dx.doi.org/10.1186/1741-7015-9-99

Ejemplares similares